Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Preliminary results
T2 Biosystems, Inc. (TTOO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
10/12/2023 8-K Quarterly results
08/24/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/18/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/11/2023 8-K Quarterly results, Conference call transcript
Docs: "T2 Biosystems Announces Second Quarter 2023 Financial Results",
"Transcript of conference call held on August 7, 2023"
08/09/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "T2 Biosystems Regains Compliance with Nasdaq's Market Value of Listed Securities Requirement LEXINGTON, Mass., August 9, 2023"
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/31/2023 8-K Quarterly results
07/31/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/26/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
07/20/2023 8-K Quarterly results
07/13/2023 SC 13G CR Group L.P. reports a 19.9% stake in T2 Biosystems, Inc.
07/12/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/12/2023 8-K Quarterly results
07/12/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
07/06/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Certificate of Designation of Preferences, Rights and Limitations of Series A Preferred Stock",
"Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock",
"Purchase Agreement, by and between the Company and the Purchasers party thereto",
"Securities Purchase Agreement, by and between the Company and the Lenders party thereto",
"Consent to Term Loan Agreement, by and between the Company and CRG Servicing LLC, as administrative agent and collateral agent, and the lenders party thereto"
06/30/2023 SC 13G GSA CAPITAL PARTNERS LLP reports a 15.2% stake in T2 Biosystems Ord
06/16/2023 SC 13G Markey John reports a 17.3% stake in T2 Biosystems, Inc.
06/12/2023 SC 13G Markey John reports a 9.9% stake in T2 Biosystems, Inc.
06/09/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/09/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "T2 Biosystems Announces Clinical Collaboration with Vanderbilt University Medical Center to Implement and Evaluate the T2Bacteria Panel for Clinical Use"
05/30/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/25/2023 8-K Quarterly results, Conference call transcript
Docs: "T2 Biosystems Announces First Quarter 2023 Financial Results",
"Transcript of conference call held on May 23, 2023"
05/23/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/15/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/31/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
03/16/2023 8-K Quarterly results, Conference call transcript
Docs: "T2 Biosystems Announces Fourth Quarter and Full Year 2022 Financial Results",
"Transcript of conference call held on March 13, 2023"
02/13/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
02/13/2023 8-K Quarterly results
01/23/2023 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Results of Operations and Financi...
Docs: "T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results"
11/25/2022 8-K Quarterly results
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/10/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy